Michael Bolick, CEO, Selah Genomics
February 4, 2013
Recently, Selah Genomics announced the acquisition of EnGenCore LLC in Columbia, SC, a move that gives them an important initial footprint at the University of South Carolina. USC recently joined forces with theGreenville Health System to launch one of the nation’s newest and mostprogressive medical schools. The USC Medical School is located inGreenville.
Selah Genomics’ first Clinical Genomics Center is physicallylocated at the GHS Institute for Translational Oncology Research (ITOR)in close proximity to the new USC medical school. This acquisitionhelps the company assist in the development of molecular and genomic technologyat USC with an eye towards helping translate this technologyto the clinic.
We sat down to talk with Selah’s CEO, Michael Bolick about the incredible opportunities ahead.
We see great potential for growth in Columbia. John Busch and his team at EnGenCore have done an outstanding job crafting this very attractive business.
